MRK: Merck & Co., Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 277,308.14
Enterprise Value ($M) 303,858.14
Book Value ($M) 40,424.00
Book Value / Share 15.95
Price / Book 6.86
NCAV ($M) -30,777.00
NCAV / Share -12.14
Price / NCAV -9.01

Profitability (mra)
Return on Invested Capital (ROIC) 0.18
Return on Assets (ROA) 0.13
Return on Equity (ROE) 0.35

Liquidity (mrq)
Quick Ratio 1.22
Current Ratio 1.47

Balance Sheet (mrq) ($M)
Current Assets 38,205.00
Assets 112,630.00
Liabilities 68,982.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Vanguard Group Inc 9.66 7.73
01-26 13G/A BlackRock Inc. 8.00 -6.13

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-11-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-10-11 558,972 6,593,727 8.48
2024-10-10 591,950 4,300,129 13.77
2024-10-09 1,143,411 6,584,460 17.37
2024-10-08 774,733 6,491,726 11.93

(click for more detail)

Similar Companies
HYAC – Haymaker Acquisition Corp. 4 JNJ – Johnson & Johnson
LLY – Eli Lilly and Company NUVB – Nuvation Bio Inc.
OGN – Organon & Co.


Financial data and stock pages provided by
Fintel.io

Finpedia: Merck & Co